Antiplatelet Switch Still Has Bleeding Risks (CME/CE)

(MedPage Today) -- Switching high-risk patients to clopidogrel (Plavix) can help counteract the low platelet reactivity common with prasugrel (Effient), but doing so has risks of its own, a first-of-its-kind study found.
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news